These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1708290)

  • 41. Long-term verapamil treatment increases [3H]imipramine binding in human platelets.
    Cohen A; Weizman A; Eldar M; Rehavi M
    Eur J Pharmacol; 1990 Jun; 181(3):311-4. PubMed ID: 2166676
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Platelet [3H]imipramine binding in psychiatric disorders.
    Kanof PD; Coccaro EF; Johns CA; Siever LJ; Davis KL
    Biol Psychiatry; 1987 Mar; 22(3):278-86. PubMed ID: 3028513
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Altered platelet 3H-imipramine binding in schizo-affective and depressive disorders.
    Suranyi-Cadotte BE; Wood PL; Schwartz G; Nair NP
    Biol Psychiatry; 1983 Aug; 18(8):923-7. PubMed ID: 6311293
    [No Abstract]   [Full Text] [Related]  

  • 44. Inhibition of [3H]imipramine binding and [3H]5-HT uptake in human platelets by some natural indoleamine and catecholamine aldehyde condensation products.
    Brusov OS; Fomenko AM; Katasonov AB
    Eur J Pharmacol; 1984 Aug; 103(1-2):191-2. PubMed ID: 6090176
    [No Abstract]   [Full Text] [Related]  

  • 45. Platelet [3H]-imipramine binding is not modified in Alzheimer's disease.
    Galzin AM; Davous P; Roudier M; Lamour Y; Poirier MF; Langer SZ
    Psychiatry Res; 1989 Jun; 28(3):289-94. PubMed ID: 2548223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Binding of [3H]Ro 11-2465. Possible identification of a subclass of [3H]imipramine binding sites.
    Dumbrille-Ross A; Tang SW
    Mol Pharmacol; 1983 May; 23(3):607-13. PubMed ID: 6306430
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Relation between the binding of 3H-imipramine and the uptake of catecholamines in synaptosomal preparations of the rat brain after chronic treatment with imipramine].
    Dagonneau H; Fonlupt P; Pacheco H
    C R Seances Soc Biol Fil; 1984; 178(1):38-44. PubMed ID: 6331605
    [TBL] [Abstract][Full Text] [Related]  

  • 48. No correlation between platelet imipramine binding and CSF 5HIAA in neurosurgical patients.
    Stoff DM; Goldman W; Bridger WH; Jain AK; Pylypiw A
    Psychiatry Res; 1990 Sep; 33(3):323-6. PubMed ID: 1700859
    [No Abstract]   [Full Text] [Related]  

  • 49. Modulation of neuronal serotonin uptake by a putative endogenous ligand of imipramine recognition sites.
    Barbaccia ML; Gandolfi O; Chuang DM; Costa E
    Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5134-8. PubMed ID: 6308674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Depressed patients have decreased binding of tritiated imipramine to platelet serotonin "transporter".
    Paul SM; Rehavi M; Skolnick P; Ballenger JC; Goodwin FK
    Arch Gen Psychiatry; 1981 Dec; 38(12):1315-7. PubMed ID: 7316676
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Imipramine binding to platelets of children with attention deficit disorder with hyperactivity.
    Weizman A; Bernhout E; Weitz R; Tyano S; Rehavi M
    Biol Psychiatry; 1988 Mar; 23(5):491-6. PubMed ID: 2830919
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differences between sodium-dependent and desipramine-defined [3H]imipramine binding in intact human platelets.
    Hrdina PD
    Biol Psychiatry; 1989 Mar; 25(5):576-84. PubMed ID: 2537664
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Platelet imipramine binding in children and adolescents with impulsive behavior.
    Birmaher B; Stanley M; Greenhill L; Twomey J; Gavrilescu A; Rabinovich H
    J Am Acad Child Adolesc Psychiatry; 1990 Nov; 29(6):914-8. PubMed ID: 2177056
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreased platelet imipramine binding in Tourette syndrome children with obsessive-compulsive disorder.
    Weizman A; Mandel A; Barber Y; Weitz R; Cohen A; Mester R; Rehavi M
    Biol Psychiatry; 1992 Apr; 31(7):705-11. PubMed ID: 1318082
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electroconvulsive shock therapy and maximum binding of platelet tritiated imipramine binding in depression.
    Langer SZ; Sechter D; Loo H; Raisman R; Zarifian E
    Arch Gen Psychiatry; 1986 Oct; 43(10):949-52. PubMed ID: 3019267
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Examination of the relationship between the uptake system for 5-hydroxytryptamine and the high-affinity [3H]imipramine binding site--I. Inhibition by drugs.
    Wood MD; Broadhurst AM; Wyllie MG
    Neuropharmacology; 1986 May; 25(5):519-25. PubMed ID: 3016589
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Circannual variations in the density of tritiated imipramine binding sites on blood platelets in man.
    Egrise D; Desmedt D; Schoutens A; Mendlewicz J
    Neuropsychobiology; 1983; 10(2-3):101-2. PubMed ID: 6325993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Isolation of substances inhibiting the specific binding of imipramine and serotonin uptake from the brain of the bull].
    Mukhin AG; Kladnitskiĭ AV; Kovaleva ES; Kudriakova TB
    Biull Eksp Biol Med; 1985 Aug; 100(8):197-9. PubMed ID: 2992631
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Unaltered platelet [3H]-imipramine binding in dementia of the Alzheimer type.
    Weizman R; Dick J; Mosek A; Tyano S; Rehavi M
    Neuropsychobiology; 1988; 19(2):69-72. PubMed ID: 2852311
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 3H-imipramine binding in platelets: influence of varying proportions of intact platelets in membrane preparations on binding.
    Friedl W; Propping P; Weck B
    Psychopharmacology (Berl); 1983; 80(1):96-9. PubMed ID: 6306712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.